| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.089 | 0.3 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.029 | 0.3 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.3 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.18 | 0.3 |